nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—Premature labour—Progesterone—uterine cancer	0.166	0.166	CcSEcCtD
Gonadorelin—Ectopic pregnancy—Medroxyprogesterone Acetate—uterine cancer	0.0998	0.0998	CcSEcCtD
Gonadorelin—Ovarian hyperstimulation syndrome—Progesterone—uterine cancer	0.0952	0.0952	CcSEcCtD
Gonadorelin—Abortion spontaneous—Progesterone—uterine cancer	0.0586	0.0586	CcSEcCtD
Gonadorelin—Abortion spontaneous—Medroxyprogesterone Acetate—uterine cancer	0.0531	0.0531	CcSEcCtD
Gonadorelin—Ovarian cyst—Progesterone—uterine cancer	0.0325	0.0325	CcSEcCtD
Gonadorelin—Ovarian cyst—Medroxyprogesterone Acetate—uterine cancer	0.0294	0.0294	CcSEcCtD
Gonadorelin—Thromboembolism—Progesterone—uterine cancer	0.025	0.025	CcSEcCtD
Gonadorelin—Thromboembolism—Medroxyprogesterone Acetate—uterine cancer	0.0226	0.0226	CcSEcCtD
Gonadorelin—Congenital anomaly—Medroxyprogesterone Acetate—uterine cancer	0.0189	0.0189	CcSEcCtD
Gonadorelin—Developmental delay—Medroxyprogesterone Acetate—uterine cancer	0.0189	0.0189	CcSEcCtD
Gonadorelin—Embolism venous—Progesterone—uterine cancer	0.0157	0.0157	CcSEcCtD
Gonadorelin—Embolism venous—Medroxyprogesterone Acetate—uterine cancer	0.0142	0.0142	CcSEcCtD
Gonadorelin—Embolism—Progesterone—uterine cancer	0.0124	0.0124	CcSEcCtD
Gonadorelin—Pelvic pain—Medroxyprogesterone Acetate—uterine cancer	0.0118	0.0118	CcSEcCtD
Gonadorelin—Redness—Progesterone—uterine cancer	0.0118	0.0118	CcSEcCtD
Gonadorelin—Embolism—Medroxyprogesterone Acetate—uterine cancer	0.0112	0.0112	CcSEcCtD
Gonadorelin—Breast pain—Progesterone—uterine cancer	0.00909	0.00909	CcSEcCtD
Gonadorelin—Dysmenorrhoea—Progesterone—uterine cancer	0.00873	0.00873	CcSEcCtD
Gonadorelin—Breast pain—Medroxyprogesterone Acetate—uterine cancer	0.00824	0.00824	CcSEcCtD
Gonadorelin—Dysmenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00791	0.00791	CcSEcCtD
Gonadorelin—Thromboembolism—Epirubicin—uterine cancer	0.00715	0.00715	CcSEcCtD
Gonadorelin—Injection site reaction—Medroxyprogesterone Acetate—uterine cancer	0.00715	0.00715	CcSEcCtD
Gonadorelin—Thromboembolism—Doxorubicin—uterine cancer	0.00662	0.00662	CcSEcCtD
Gonadorelin—Swelling—Progesterone—uterine cancer	0.00653	0.00653	CcSEcCtD
Gonadorelin—Swelling—Medroxyprogesterone Acetate—uterine cancer	0.00592	0.00592	CcSEcCtD
Gonadorelin—Breast disorder—Progesterone—uterine cancer	0.0052	0.0052	CcSEcCtD
Gonadorelin—Abdominal discomfort—Progesterone—uterine cancer	0.00477	0.00477	CcSEcCtD
Gonadorelin—Breast disorder—Medroxyprogesterone Acetate—uterine cancer	0.00472	0.00472	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Progesterone—uterine cancer	0.00463	0.00463	CcSEcCtD
Gonadorelin—Pain—Carboplatin—uterine cancer	0.00461	0.00461	CcSEcCtD
Gonadorelin—Embolism venous—Epirubicin—uterine cancer	0.00451	0.00451	CcSEcCtD
Gonadorelin—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00432	0.00432	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00419	0.00419	CcSEcCtD
Gonadorelin—Embolism venous—Doxorubicin—uterine cancer	0.00417	0.00417	CcSEcCtD
Gonadorelin—Pelvic pain—Epirubicin—uterine cancer	0.00374	0.00374	CcSEcCtD
Gonadorelin—Angiopathy—Progesterone—uterine cancer	0.00361	0.00361	CcSEcCtD
Gonadorelin—Immune system disorder—Progesterone—uterine cancer	0.0036	0.0036	CcSEcCtD
Gonadorelin—Embolism—Epirubicin—uterine cancer	0.00354	0.00354	CcSEcCtD
Gonadorelin—Erythema—Progesterone—uterine cancer	0.00347	0.00347	CcSEcCtD
Gonadorelin—Pelvic pain—Doxorubicin—uterine cancer	0.00346	0.00346	CcSEcCtD
Gonadorelin—Flatulence—Progesterone—uterine cancer	0.00342	0.00342	CcSEcCtD
Gonadorelin—Redness—Epirubicin—uterine cancer	0.00337	0.00337	CcSEcCtD
Gonadorelin—Swelling—Etoposide—uterine cancer	0.00334	0.00334	CcSEcCtD
Gonadorelin—Embolism—Doxorubicin—uterine cancer	0.00328	0.00328	CcSEcCtD
Gonadorelin—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00328	0.00328	CcSEcCtD
Gonadorelin—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00326	0.00326	CcSEcCtD
Gonadorelin—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00314	0.00314	CcSEcCtD
Gonadorelin—Redness—Doxorubicin—uterine cancer	0.00312	0.00312	CcSEcCtD
Gonadorelin—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.0031	0.0031	CcSEcCtD
Gonadorelin—Anaphylactic shock—Progesterone—uterine cancer	0.00283	0.00283	CcSEcCtD
Gonadorelin—Shock—Progesterone—uterine cancer	0.00279	0.00279	CcSEcCtD
Gonadorelin—Nervous system disorder—Progesterone—uterine cancer	0.00278	0.00278	CcSEcCtD
Gonadorelin—Breast pain—Epirubicin—uterine cancer	0.00261	0.00261	CcSEcCtD
Gonadorelin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00257	0.00257	CcSEcCtD
Gonadorelin—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00252	CcSEcCtD
Gonadorelin—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00252	CcSEcCtD
Gonadorelin—Erythema—Dactinomycin—uterine cancer	0.00245	0.00245	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Progesterone—uterine cancer	0.00244	0.00244	CcSEcCtD
Gonadorelin—Fatigue—Progesterone—uterine cancer	0.00244	0.00244	CcSEcCtD
Gonadorelin—Pain—Progesterone—uterine cancer	0.00242	0.00242	CcSEcCtD
Gonadorelin—Constipation—Progesterone—uterine cancer	0.00242	0.00242	CcSEcCtD
Gonadorelin—Breast pain—Doxorubicin—uterine cancer	0.00241	0.00241	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Progesterone—uterine cancer	0.00231	0.00231	CcSEcCtD
Gonadorelin—Injection site reaction—Epirubicin—uterine cancer	0.00226	0.00226	CcSEcCtD
Gonadorelin—Abdominal pain—Progesterone—uterine cancer	0.00224	0.00224	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00221	0.00221	CcSEcCtD
Gonadorelin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00221	0.00221	CcSEcCtD
Gonadorelin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00219	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.0021	CcSEcCtD
Gonadorelin—Injection site reaction—Doxorubicin—uterine cancer	0.00209	0.00209	CcSEcCtD
Gonadorelin—Hypersensitivity—Progesterone—uterine cancer	0.00209	0.00209	CcSEcCtD
Gonadorelin—Asthenia—Progesterone—uterine cancer	0.00203	0.00203	CcSEcCtD
Gonadorelin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00203	0.00203	CcSEcCtD
Gonadorelin—Pruritus—Progesterone—uterine cancer	0.002	0.002	CcSEcCtD
Gonadorelin—Diarrhoea—Progesterone—uterine cancer	0.00194	0.00194	CcSEcCtD
Gonadorelin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00189	CcSEcCtD
Gonadorelin—Angiopathy—Etoposide—uterine cancer	0.00185	0.00185	CcSEcCtD
Gonadorelin—Immune system disorder—Etoposide—uterine cancer	0.00184	0.00184	CcSEcCtD
Gonadorelin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00184	CcSEcCtD
Gonadorelin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00181	CcSEcCtD
Gonadorelin—Vomiting—Progesterone—uterine cancer	0.0018	0.0018	CcSEcCtD
Gonadorelin—Headache—Progesterone—uterine cancer	0.00177	0.00177	CcSEcCtD
Gonadorelin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00176	CcSEcCtD
Gonadorelin—Fatigue—Dactinomycin—uterine cancer	0.00172	0.00172	CcSEcCtD
Gonadorelin—Pain—Dactinomycin—uterine cancer	0.00171	0.00171	CcSEcCtD
Gonadorelin—Nausea—Progesterone—uterine cancer	0.00168	0.00168	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00164	0.00164	CcSEcCtD
Gonadorelin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00163	CcSEcCtD
Gonadorelin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00161	CcSEcCtD
Gonadorelin—Abdominal pain—Dactinomycin—uterine cancer	0.00158	0.00158	CcSEcCtD
Gonadorelin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00152	CcSEcCtD
Gonadorelin—Breast disorder—Epirubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Gonadorelin—Hypersensitivity—Dactinomycin—uterine cancer	0.00147	0.00147	CcSEcCtD
Gonadorelin—Anaphylactic shock—Etoposide—uterine cancer	0.00145	0.00145	CcSEcCtD
Gonadorelin—Asthenia—Dactinomycin—uterine cancer	0.00144	0.00144	CcSEcCtD
Gonadorelin—Breast disorder—Doxorubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Gonadorelin—Diarrhoea—Dactinomycin—uterine cancer	0.00137	0.00137	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00133	0.00133	CcSEcCtD
Gonadorelin—Vomiting—Dactinomycin—uterine cancer	0.00127	0.00127	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Etoposide—uterine cancer	0.00125	0.00125	CcSEcCtD
Gonadorelin—Fatigue—Etoposide—uterine cancer	0.00125	0.00125	CcSEcCtD
Gonadorelin—Constipation—Etoposide—uterine cancer	0.00124	0.00124	CcSEcCtD
Gonadorelin—Pain—Etoposide—uterine cancer	0.00124	0.00124	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00123	0.00123	CcSEcCtD
Gonadorelin—Nausea—Dactinomycin—uterine cancer	0.00119	0.00119	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Etoposide—uterine cancer	0.00118	0.00118	CcSEcCtD
Gonadorelin—Abdominal pain—Etoposide—uterine cancer	0.00114	0.00114	CcSEcCtD
Gonadorelin—Hypersensitivity—Etoposide—uterine cancer	0.00107	0.00107	CcSEcCtD
Gonadorelin—Asthenia—Etoposide—uterine cancer	0.00104	0.00104	CcSEcCtD
Gonadorelin—Angiopathy—Epirubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Gonadorelin—Immune system disorder—Epirubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Gonadorelin—Pruritus—Etoposide—uterine cancer	0.00102	0.00102	CcSEcCtD
Gonadorelin—Erythema—Epirubicin—uterine cancer	0.000995	0.000995	CcSEcCtD
Gonadorelin—Diarrhoea—Etoposide—uterine cancer	0.000991	0.000991	CcSEcCtD
Gonadorelin—Flatulence—Epirubicin—uterine cancer	0.00098	0.00098	CcSEcCtD
Gonadorelin—Angiopathy—Doxorubicin—uterine cancer	0.000959	0.000959	CcSEcCtD
Gonadorelin—Immune system disorder—Doxorubicin—uterine cancer	0.000955	0.000955	CcSEcCtD
Gonadorelin—Vomiting—Etoposide—uterine cancer	0.000921	0.000921	CcSEcCtD
Gonadorelin—Erythema—Doxorubicin—uterine cancer	0.00092	0.00092	CcSEcCtD
Gonadorelin—Headache—Etoposide—uterine cancer	0.000907	0.000907	CcSEcCtD
Gonadorelin—Flatulence—Doxorubicin—uterine cancer	0.000907	0.000907	CcSEcCtD
Gonadorelin—Nausea—Etoposide—uterine cancer	0.00086	0.00086	CcSEcCtD
Gonadorelin—Anaphylactic shock—Epirubicin—uterine cancer	0.000812	0.000812	CcSEcCtD
Gonadorelin—Shock—Epirubicin—uterine cancer	0.000799	0.000799	CcSEcCtD
Gonadorelin—Nervous system disorder—Epirubicin—uterine cancer	0.000796	0.000796	CcSEcCtD
Gonadorelin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000751	0.000751	CcSEcCtD
Gonadorelin—Shock—Doxorubicin—uterine cancer	0.000739	0.000739	CcSEcCtD
Gonadorelin—Nervous system disorder—Doxorubicin—uterine cancer	0.000737	0.000737	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000701	0.000701	CcSEcCtD
Gonadorelin—Fatigue—Epirubicin—uterine cancer	0.0007	0.0007	CcSEcCtD
Gonadorelin—Constipation—Epirubicin—uterine cancer	0.000694	0.000694	CcSEcCtD
Gonadorelin—Pain—Epirubicin—uterine cancer	0.000694	0.000694	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000664	0.000664	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000648	0.000648	CcSEcCtD
Gonadorelin—Fatigue—Doxorubicin—uterine cancer	0.000648	0.000648	CcSEcCtD
Gonadorelin—Pain—Doxorubicin—uterine cancer	0.000642	0.000642	CcSEcCtD
Gonadorelin—Constipation—Doxorubicin—uterine cancer	0.000642	0.000642	CcSEcCtD
Gonadorelin—Abdominal pain—Epirubicin—uterine cancer	0.000642	0.000642	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000614	0.000614	CcSEcCtD
Gonadorelin—Hypersensitivity—Epirubicin—uterine cancer	0.000598	0.000598	CcSEcCtD
Gonadorelin—Abdominal pain—Doxorubicin—uterine cancer	0.000594	0.000594	CcSEcCtD
Gonadorelin—Asthenia—Epirubicin—uterine cancer	0.000582	0.000582	CcSEcCtD
Gonadorelin—Pruritus—Epirubicin—uterine cancer	0.000574	0.000574	CcSEcCtD
Gonadorelin—Diarrhoea—Epirubicin—uterine cancer	0.000555	0.000555	CcSEcCtD
Gonadorelin—Hypersensitivity—Doxorubicin—uterine cancer	0.000553	0.000553	CcSEcCtD
Gonadorelin—Asthenia—Doxorubicin—uterine cancer	0.000539	0.000539	CcSEcCtD
Gonadorelin—Pruritus—Doxorubicin—uterine cancer	0.000531	0.000531	CcSEcCtD
Gonadorelin—Vomiting—Epirubicin—uterine cancer	0.000516	0.000516	CcSEcCtD
Gonadorelin—Diarrhoea—Doxorubicin—uterine cancer	0.000514	0.000514	CcSEcCtD
Gonadorelin—Headache—Epirubicin—uterine cancer	0.000509	0.000509	CcSEcCtD
Gonadorelin—Nausea—Epirubicin—uterine cancer	0.000482	0.000482	CcSEcCtD
Gonadorelin—Vomiting—Doxorubicin—uterine cancer	0.000478	0.000478	CcSEcCtD
Gonadorelin—Headache—Doxorubicin—uterine cancer	0.000471	0.000471	CcSEcCtD
Gonadorelin—Nausea—Doxorubicin—uterine cancer	0.000446	0.000446	CcSEcCtD
